Two Cell is Drug Discovery in Japan that focus on biomedical research business. Founded in 2003. They cover business area such as Provider, biomedical research and development service, research service, therapeutic gene, cell, drug, diagnostic agent, chemical reagent, medical material, diagnosis method, disease treatment, healthcare professional, regenerative medicine.
2003
( 21 years old in 2024 )
Biomedical Research
-
Hiroshima Industrial Culture Center 11th floor, 16-35
Hijiyamahonmachi, Minami-ku, Hiroshima Prefecture
Hiroshima, 732-0816
Japan
Private
Providerbiomedical research and development serviceresearch servicetherapeutic genecelldrugdiagnostic agentchemical reagentmedical materialdiagnosis methoddisease treatmenthealthcare professionalregenerative medicine
* We use standard office opening hours in near Two Cell's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Two Cell is Drug Discovery business from Japan that founded in 2003 (21 years old in 2024), Two Cell business is focusing on Biomedical Research.
Two Cell headquarter office and corporate office address is located in Hiroshima Industrial Culture Center 11th floor, 16-35 Hijiyamahonmachi, Minami-ku, Hiroshima Prefecture Hiroshima, 732-0816 Japan.
Two Cell was founded in Japan.
In 2024, Two Cell is currently focus on biomedical research sector.
Above is snippet of Google Trends for "biomedical research" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Two Cell, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
